Medindia

X

MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014

Thursday, September 17, 2009 General News J E 4
Advertisement
WILMINGTON, Delaware, September 1 According to a newmarket research report, 'Global Autoimmune Treatment Market (2009-2014)',published by MarketsandMarkets ( http://www.marketsandmarkets.com), theglobal autoimmune treatment market is expected to be worth US$68.81 billionby 2014, with an estimated CAGR of 12.7% from 2009 to 2014. The NorthAmerican market is expected to account for nearly 42% of the total revenues.

Browse 100+ market data tables and in-depth TOC on autoimmune treatmentmarket.

Early buyers will receive 10% customization of reports

http://www.marketsandmarkets.com/Market-Reports/autoimmune-treatment-mark

et-research-27.html

(Due to the length of this URL, it may be necessary to copy and pastethis hyperlink into your Internet browser's URL address field. Remove thespace if one exists.)

Autoimmune disorders result from an overactive immune response of a bodyworking against its own cells. The disease is broadly classified into twotypes: systemic autoimmune diseases, which affect several organs of the body;and localized autoimmune diseases, which affect only one organ. Around 80autoimmune diseases are recognized under these two categories. The diseaseaffected over 300 million people across the globe in 2009. No defined reasonshave been discovered to date for the occurrence of the disorder. Women aremore prone to autoimmune diseases, constituting 70%-75% of all autoimmunepatients.

The global market for autoimmune disease treatments is estimated to be at$37.84 billion in 2009 and is growing at a CAGR of 12.7% from 2009 to 2014.The market is forecasted to be at $68.81 billion in 2014. The effects of theglobal meltdown are given careful consideration when forecasting the market.As autoimmune disorders still have no permanent cure, more and morepharmaceutical companies are making significant R&D investments into findingtreatments for autoimmune diseases, are also focusing on finding the causesbehind the disease, which again are unknown.

The overall market for the treatment of autoimmune disorders is analyzedinto the submarkets for applications, products, services, and technologies.The application market is further classified into the treatment markets forsystemic autoimmune diseases and localized autoimmune diseases. Theapplications market is dominated mostly by rheumatoid arthritis under thesystemic disease segment, while multiple sclerosis is the major applicationmarket under the localized disease segment. These two disorders account for75% of the total applications market. The other major diseases analysed underthe application market are psoriasis, lupus, type I diabetes, inflammatorybowel disease, and thyroid disorders, which together account for 15%-20% ofthe global applications market.

The product market is classified on the basis of the drugs, diagnosticequipments, therapeutic and monitoring equipment. Drugs form the largestsegment of the products market, with major drugs such as NSAID, DMARD,biologic DMARD, Avonex, Rebif, Copaxone, Betaseron, and 5-ASA. The servicesmarket consists of consultation and diagnosis, therapy and monitoring, anddrug development. The wide and increasing prevalence of autoimmune diseasesis boosting the drugs market along with the therapy and monitoring market;along with the fact that almost all autoimmune diseases are chronic and haveno permanent cure.

Scope of the Report

The report provides market overviews, market forecasts, market driversand restraints for the autoimmune treatment market. In addition, the reportprofiles the top forty market players and their respective autoimmuneproducts. The report identifies and analyzes the market according toapplication markets for both systemic and localized autoimmune diseases,product markets, services market, and technologies market.

Autoimmune Treatment - Products

Drugs, diagnostic equipments, therapeutic and monitoring equipments andother products.

Autoimmune Treatment - Services

Consultation & Diagnosis, Therapy & Monitoring, Drug Development andother services.

Autoimmune Treatment - Technologies

DMARD (disease-modifying anti-rheumatic drugs) and biologic DMARDtherapy, Bridge therapy, Topical therapy, Phototherapy, Helminthic therapy,Fecal bacteriotherapy, Haematopoietic stem-cell transplantation, Recombinanttechnology

Analyst Briefings on 15th Sep 2009.

The Pharmaceuticals practice at MarketsandMarkets is pleased to announceits Analyst Briefing Presentation on the Global Autoimmune Treatment Marketto be held on 15th Sep 2009. The briefing on the Global Autoimmune TreatmentMarket (2009-2014) will benefit the drug manufacturers, therapeutic anddiagnostic equipment manufacturers, researchers and consultation and therapyservice providers.

To register your participation, please click herehttp://www.marketsandmarkets.com/AnalystBriefing/analyst-briefing-global-biomaterial-market.asp

(Due to the length of this URL, it may be necessary to copy and pastethis hyperlink into your Internet browser's URL address field. Remove thespace if one exists.)

Contact our representative to sponsor this report

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120market research reports (http://www.marketsandmarkets.com) per year. Eachstrategically analyzed report contains 250 pages of valuable market data,including more than 100 market data summary tables and in-depth, five-levelsegmentation for each of the products, services, applications, technologies,ingredients and stakeholders categories. Our reports also analyze about 200patents, over 50 companies and micro markets that are mutually exclusive andcollectively exhaustive. Browse all our 120 titles athttp://www.marketsandmarkets.com.Autoimmune Treatment - Applications - Systemic autoimmune diseases - rheumatoid arthritis, psoriasis, lupus and other systemic autoimmune diseases. - Localized autoimmune diseases - multiple sclerosis, inflammatory bowel disease, diabetes, thyroid and other localized autoimmune diseases.

SOURCE Markets and Markets
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Global Biomaterials Market Worth US$58.1 Billion b...
S
Stemgent Announces Sponsorship of Harvard Stem Cel...